Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
the inspection conducted from January 27 to January 31, 2025
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
The company will initially supply prototypes to diverse customers to evaluate in purification processes for producing gene therapy drugs with a view to swift commercialization
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
The brand Magtein by Threotech has a sales value of approximately US $438 million
Subscribe To Our Newsletter & Stay Updated